<DOC>
	<DOCNO>NCT02700815</DOCNO>
	<brief_summary>This randomise , control multi-centre parallel group trial ass efficacy tolerability topical formulation gel combination diclofenac capsaicin comparison gel diclofenac alone , capsaicin alone , placebo treatment acute back pain neck pain</brief_summary>
	<brief_title>Capsaicin + Diclofenac Gel Acute Back Pain Neck Pain</brief_title>
	<detailed_description />
	<mesh_term>Neck Pain</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Inclusion criterion : Signed date write informed consent Visit 1 accordance Good Clinical Practice local legislation Male female patient &gt; =18 year current diagnosis acute back pain neck pain least 24 hour , less 21 day Acute back pain acute neck pain result pain movement ( POM ) &gt; = 50 mm ( Visual Analogue Scale 0100 ) least one POM procedure 5 standardized procedure . Sensitivity algometric pressure painful trigger point &lt; = 25 N/cm2 Women childbearing potential must ready able use highly effective method birth control Exclusion criterion : History 3 episode back neck pain last 6 month exclude current episode Surgery due back neck pain rehabilitation due back neck pain last 12 month Back neck pain attributable specific identifiable cause ( e.g . disc prolapse , spondylolisthesis , osteomalacia , inflammatory arthritis , metabolic , neurological disease tumour ) Trauma strain back neck muscle within last 3 month Prior use within last 3 day Visit 1 concomitant use antiinflammatory drug , heparinoids , muscle relaxant analgesic . Longacting glucocorticoid must discontinue 10 day study entry . Spinal injection discontinue due time ( investigator 's judgement ) patient enrolment allow complete washout active ingredient base investigator 's judgment Nonpharmacological treatment ( physiotherapy , heat treatment ( e.g . heat patch , hot water bottle ) , massage , acupuncture , transcutaneous electrical nerve stimulation ) locally apply pharmacological product back neck area 24 hour prior study entry study period Known severe hepatocellular insufficiency , severe renal insufficiency Gilbert 's syndrome ( Morbus Meulengracht ) Any medical condition would interfere efficacy safety assessment base investigator 's judgement ongoing clinical condition would jeopardize patient 's site personnel 's safety study compliance base investigator judgement . Known intolerance hypersensitivity active ingredient excipient ( ) . Patients attack asthma , bronchospasm , rhinitis urticaria precipitate intake ASS NSAIDs Irritated skin ( base investigator 's judgement ) , skin wound , eczema open injury application site Negative experience past heat treatment muscle complaint Patient able understand comply trial requirement base investigator judgement Alcohol drug abuse Participation clinical trial within previous 30 day simultaneous participation another clinical trial Women pregnant , nursing , plan become pregnant trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>